Yoshifumi Tachibana

Critic
DISC Type : C

Head of Experimental Medicine Inflammation at Boehringer Ingelheim

Tokyo, Tokyo, Japan

Overview

Yoshifumi Tachibana is the Head of Experimental Medicine Inflammation at Boehringer Ingelheim Japan. With a PhD from Kitasato University and a Project Management Professional (PMP) certification, he specializes in global clinical development and operations, particularly in oncology and inflammation.

He has published extensive research on the subject of "drug lag"—the delay in new drug availability in Japan compared to the U. S. —and is focused on enhancing the accessibility of novel medicines for patients.

Personality Overview

Information Seeker

ROI Driven

Precise

They like to take decisions independently and do not seek others' support often.  They prefer to analyze logically and value objective facts over emotions. Unless the value is proven by data, they are unlikely to value fancy features.

Topics They Care About

Oncology Drug Development
He has a deep background in oncology clinical trials from previous roles and has published multiple academic papers on the approval process for oncology drugs in Japan.
Global Clinical Trials
His experience includes leading multi-regional trials across Asia, Europe, and the Americas, focusing on streamlining international drug development.
Pharmaceutical Policy
His research specifically analyzes the "drug lag" between US and Japanese approvals, showing a keen interest in the regulatory and policy aspects of market access.

Media Appearances

Yoshifumi has no verified media appearances

Work History

7-2025
Head of Experimental Medicine Inflammation at Boehringer Ingelheim
1-2024 - 6-2025
Head of CTL, Clinical Development and Operations Japan at Boehringer Ingelheim
11-2010 - 12-2023
Clinical Trial Leader at Boehringer Ingelheim
4-2004 - 10-2010
Clinical Team Leader at Taiho Pharmaceutical Co., Ltd.,

Education

4-2022 - 3-2025
Doctor of Philosophy - PhD from Kitasato University
4-2020 - 3-2022
Executive MBA from NUCB Business School

More Information

Social Presence :

Prographics :

Exp : 21 Location : Tokyo, Tokyo, Japan Job Level : Mid-senior Designation : Head of Experimental Medicine Inflammation at Boehringer Ingelheim
URL has been copied!

Insights For Selling To Yoshifumi

During A Call Or A Meeting

DO's

  • Be formal and objective, they will appreciate it more
  • Leverage facts and figures wherever possible; use percentages, numbers etc.
  • Keep some extra margin while sharing pricing, they are likely to negotiate later

DONT's

  • Don’t try to give too many examples of other users, they like to make their own decisions
  • Make extra effort to not seem pushy or confrontational
  • Don’t try too hard to build a relationship with them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Yoshifumi is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Yoshifumi

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Yoshifumi move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Yoshifumi take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Yoshifumi

Personality Compatibility


Other Boehringer Ingelheim Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.